Five details:
1. The market is expected to increase at a compound annual growth rate of 4.8 percent through 2020-2027.
2. The thoracic fusion and lumbar fusion devices sector is expected to hit $5.2 billion by 2027, increasing at a compound annual growth rate of 5.3 percent.
3. The U.S. held an estimated $2.8 billion of the market in 2020.
4. China is anticipated to grow at the quickest rate through the forecast period, reaching a market size of $3.1 billion by 2027.
5. Forty device companies are detailed in the report, including Medtronic, Globus Medical, Alphatec, DePuy Synthes and NuVasive.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
